Cannabis use and cannabis use disorder
Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …
10% of the 193 million cannabis users worldwide. The individual and public health burdens …
Cannabis-related disorders and toxic effects
DA Gorelick - New England Journal of Medicine, 2023 - Mass Medical Soc
Cannabis-Related Disorders and Toxic Effects | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Background A substantial and unmet clinical need exists for pharmacological treatment of
cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which …
cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which …
Heavy cannabis use, dependence and the brain: a clinical perspective
Aims To summarize and evaluate our knowledge of the relationship between heavy
cannabis use, cannabis use disorder (CUD) and the brain. Methods Narrative review of …
cannabis use, cannabis use disorder (CUD) and the brain. Methods Narrative review of …
The effects of cannabis use on the development of adolescents and young adults
This review summarizes evidence on the effects of cannabis use on the development of
adolescents and young adults. It draws on epidemiological studies, neuroimaging studies …
adolescents and young adults. It draws on epidemiological studies, neuroimaging studies …
Cannabidiol in the context of substance use disorder treatment: A systematic review
V Paulus, J Billieux, A Benyamina, L Karila - Addictive behaviors, 2022 - Elsevier
Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …
Bipolar disorder and comorbid use of illicit substances
UW Preuss, M Schaefer, C Born, H Grunze - Medicina, 2021 - mdpi.com
Substance use disorders (SUD) are highly prevalent in bipolar disorder (BD) and
significantly affect clinical outcomes. Incidence and management of illicit drug use differ from …
significantly affect clinical outcomes. Incidence and management of illicit drug use differ from …
[HTML][HTML] Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
FR Mendes, C dos Santos Costa, VD Wiltenburg… - Addiction …, 2022 - Elsevier
Substance use disorder (SUD) is a global public health concern that affects millions of
people worldwide. Considering current research, addiction has been noted as the last stage …
people worldwide. Considering current research, addiction has been noted as the last stage …
Pharmacotherapy for the treatment of cannabis use disorder: a systematic review
KK Kondo, BJ Morasco, SM Nugent… - Annals of internal …, 2020 - acpjournals.org
Background: Cannabis use disorder (CUD) is a growing concern, and evidence-based data
are needed to inform treatment options. Purpose: To review the benefits and risks of …
are needed to inform treatment options. Purpose: To review the benefits and risks of …
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
CN Andrews, R Rehak, M Woo, I Walker… - Alimentary …, 2022 - Wiley Online Library
Background Cannabinoid hyperemesis syndrome (CHS) is a poorly understood vomiting
disorder associated with chronic cannabis use. Aims To characterise patients experiencing …
disorder associated with chronic cannabis use. Aims To characterise patients experiencing …